Patient appointments
Starting a new psoriasis medicine often brings two questions: when should I notice a change, and what happens if it is not enough? A useful follow-up plan measures your own symptoms and safety instead of promising a fixed clearance date.
An appointment does not confirm access to a particular medicine, procedure or specialist. Ask the team about the care and coverage you need.
Medical information checked against current US sources: October 19, 2026.
Take dated photographs in similar lighting, record itch and pain, and note areas that affect sleep, clothing, movement or intimacy. Include scalp, hands, feet and nails. Bring the record to follow-up; a good day or a single photograph can miss the pattern over several weeks.
Tell the clinician what mattered most before treatment. Someone with little visible skin involvement can still have a substantial burden at a difficult site. New joint or bowel symptoms should be assessed separately rather than counted only as a change in skin response.
The ICOTYDE clinical program assessed psoriasis outcomes at defined visits, including week 16. Some trials also assessed an active comparator at week 24. A group result tells you about the studied population and endpoint; it cannot predict the exact week when your scalp, nails or body plaques will improve.
Agree on a review date with the prescriber. If there is little improvement, the review can examine the diagnosis, the dosing routine, missed doses, difficult sites and whether another approach is needed. Seek advice earlier for important side effects or worsening disease.
A switch should account for why the current treatment is changing: incomplete response, adverse effects, access problems, administration preference or another diagnosis. The prescriber needs the exact drug, last dose, other immune-active medicines and history of infections before planning timing.
Do not overlap medicines, stop a biologic early or use leftover tablets to create your own transition. There is no single washout instruction that fits all psoriasis treatments and patients. If you have psoriatic arthritis or IBD, confirm that the new plan addresses those conditions; ICOTYDE’s current US approval is for plaque psoriasis.
Before changing therapy, check who will prescribe, which pharmacy will fill it, authorization status, expected costs and what happens if a refill is delayed. A medicine sample can bridge a short supply only when the clinical team has a plan; it does not establish long-term affordability.
Bring the insurance denial or pharmacy message rather than relying on a general online claim about coverage. If treatment is interrupted, ask the prescriber how to restart. Do not double doses to compensate for the gap.
There is no guaranteed personal timeline. Clinical studies measured outcomes at scheduled visits, including week 16, but your clinician should decide when to assess your response. Track itch, plaques, difficult sites and daily function. Report worsening symptoms or adverse effects before the planned review if needed.
Not necessarily. Response can differ by site, and a scalp problem can have more than one cause. Bring photographs, the time on treatment and details of scalp products or topical prescriptions to the review. The clinician can decide whether the diagnosis, technique or treatment plan needs adjustment.
The ICOTYDE label describes studies against placebo and, in two trials, deucravacitinib. Those are not direct ICOTYDE-versus-TREMFYA trials. Comparing response percentages from separate studies can be misleading because populations and methods differ. Choose with a clinician using the diagnosis, safety, route, routine and access requirements.
Administration preference is a valid part of the discussion. An oral option still needs to match your diagnosis and safety history, and it introduces a daily fasting routine. If an injection treats joint or bowel disease as well as skin disease, the replacement plan must address those needs too.
Do not stop solely because your skin looks clear. Psoriasis is chronic, and ongoing treatment decisions depend on response, safety and your goals. Discuss duration and a review plan with the prescriber. If an infection or serious symptom occurs, seek prompt advice rather than waiting for routine follow-up.
Choose a service and clinic in the Nao booking app. Confirm appointment availability and the care you need with the team.